{
    "clinical_study": {
        "@rank": "60337", 
        "acronym": "HTNmobile", 
        "arm_group": {
            "arm_group_label": "Electronic Intervention", 
            "arm_group_type": "Experimental", 
            "description": "Over the three months, participants will receive a technology intervention.  This will include text or email encounter notifications associated with appropriate mobile or online self-management information for medication adherence and behavior change."
        }, 
        "brief_summary": {
            "textblock": "The study team is proposing a single arm intervention to test the effect of an electronic\n      intervention on medication use among individuals with a prescription for hypertension/high\n      blood pressure. The investigator proposes that technology like text messaging, email, web\n      applications and mobile apps with proven, nurse intervention scripts, will lead to\n      significant, cost-effective improvements in hypertension medication use."
        }, 
        "brief_title": "Improving Medication Adherence in Hypertensive Patients", 
        "completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Hypertension", 
        "condition_browse": {
            "mesh_term": "Hypertension"
        }, 
        "detailed_description": {
            "textblock": "The intervention will incorporate a scalable electronic intervention using Email/Web Apps\n      and Short Message Service (SMS)/Mobile Web Apps. The study team will examine the\n      participants' responses to the electronic encounters in the technology-only intervention\n      throughout the 3-month study timeframe."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Enrolled in the primary care clinic for the past 6 months\n\n          -  New or existing prescription for hypertension\n\n          -  Poorly controlled mean systolic blood pressure (SBP) in the last 12 months (>140/90\n             Hg)\n\n        Exclusion Criteria:\n\n          -  Hospitalized for a stroke, myocardial infarction, coronary artery revascularization\n             in the past 3 months,\n\n          -  Diagnosis of metastatic cancer;\n\n          -  Active diagnosis of psychosis or dementia documented in medical record;\n\n          -  Does not have access to the appropriate technology required\n\n          -  Is not willing to use said device to receive notifications for the study;\n\n          -  Does not live independently (assisted living or nursing home residents) or otherwise\n             institutionalized or receiving home health care\n\n          -  Severely impaired hearing, vision or speech (unless technological aides allow them\n             full functionality)\n\n          -  Planning to leave the area or change primary care clinics prior to the anticipated\n             end of participation;\n\n          -  Unable to read and understand spoken English\n\n          -  Participation in another cardiovascular disease (CVD) study\n\n          -  Another household member enrolled in study;\n\n          -  Arm size > 50cm"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "0", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "April 4, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01826435", 
            "org_study_id": "Pro00043793"
        }, 
        "intervention": {
            "arm_group_label": "Electronic Intervention", 
            "description": "Patients will be able to receive the intervention notifications over the electronic/multimedia mode they prefer; selecting either text messaging/mobile web and/or email/online web. Text message or email alerts with an included uniform resource locator (URL) link to the specified mobile or online web site will be utilized to notify patients of a pending encounter available on mobile.  Topics that will be addressed in the intervention include medication and side effects, social support, hypertension knowledge, memory and smoking.  All intervention encounters that are designed to collect responses from the patient will require the patient to supply credentials before responding to the encounter; thus, ensuring privacy of the patient session, as well as patient-specific tracking of responses.", 
            "intervention_name": "Electronic Intervention", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "January 24, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Durham", 
                    "country": "United States", 
                    "state": "North Carolina", 
                    "zip": "27705"
                }, 
                "name": "Duke University Health System Clinic"
            }
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Improving Medication Adherence in Hypertensive Patients", 
        "overall_status": "Withdrawn", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "August 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Proportion of Days Covered (PDC), a Pharmacy Quality Alliance (PQA)-recommended metric for estimation of medication adherence for patients using chronic medications, will be used to identify the percentage of patients taking medications in a particular drug class with high adherence (PDC > 80% for the individual). Participants with a PDC \u22640.8 will be categorized as having \"poor\" adherence, and those with a PDC >0.8 will be categorized as having \"good\" adherence.  For analyses, the PDC will be dichotomized at 0.8 (PDC >0.8) over the entire 3 month follow-up, yielding a single assessment of pill refill adherence that will be used as the primary outcome.", 
            "measure": "Proportion of Days Covered (PDC)", 
            "safety_issue": "No", 
            "time_frame": "3 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01826435"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Duke University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Duke University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2014", 
        "study_design": "Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research", 
        "study_type": "Interventional", 
        "verification_date": "January 2014", 
        "why_stopped": "Collaborator was not clear on how best to proceed with this project."
    }
}